Effect of vinorelbine on the growth of human myeloma cell lines in vitro

Leukemia Research

Volumn 26, Issue 8, 2002, Pages 731-738

  Ochiai, Naoya ^a   Shimazaki, Chihiro ^a   Inaba, Tohru ^a   Fuchida, Shin Ichi ^a   Okano, Akira ^a   Hatsuse, Mayumi ^a   Hirai, Hideyo ^a   Ashihara, Eishi ^a   Fujita, Naohisa ^a   Nakagawa, Masao ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Apoptosis; Dexamethasone; Multiple myeloma; Vinca alkaloid; Vinorelbine

Indexed keywords

DEXAMETHASONE; NAVELBINE; TRYPAN BLUE;

APOPTOSIS; ARTICLE; ASSAY; CELL GROWTH; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MYELOMA CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL DIVISION; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; HUMANS; MULTIPLE MYELOMA; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0036283691     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00195-3     Document Type: Article

References (26)

1. Plasma cell myeloma-new biological insights and advances in therapy
2. Effective treatment of advanced myeloma refractory to alkylating agents
3. Comparison of vincristine, carmustine, melphalan, cyclophosphamide, prednisolone (VBMCP) and interferon-alpha with melphalan and prednisolone (MP) and interfelon-alpha in patients with good-prognosis multiple myeloma: A prospective randomized study, Greek myeloma study group
4. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma
5. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma
6. Total therapy with tandem transplants for newly diagnosed multiple myeloma
7. Apoptosis in pathogenesis and treatment of disease
8. Raf-1/bcl-2 phosphorylation: A step from microtubule damage to cell death
9. Vinorelbine: An active drug for the management of patients with heavily pretreated Hodgkin's disease
10. The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin's disease
11. Ifosfamide and vinorelbine: An active regimen for patients with relapsed or refractory Hodgkin's disease
12. Vinorelbine in the treatment of lymphoma
13. Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture
14. Combination effect of navelbine (vinorelbine ditartrate) with cisplatin against murine P388 leukemia and human lung carcinoma xenografts in mice
15. Vinorelbine induces apoptosis and caspase-3 (CPP32) expression in leukemia and lymphoma cells: A comparison with vincristine
16. Intermittent high dose prednisone therapy for multiple myeloma
17. High-dose glucocorticoid treatment of resistant myeloma
18. Inhibition of myeloma cell growth by dexamethasone and all trans-retinoic acid: Synergy through modulation of interleukin-6 autocrine loop at multiple sites
19. Establishment of a novel myeloma cell line KPMM2 carrying t (3; 14) (q21; Q32), which proliferates specifically in response to interleukin-6 through an autocrine mechanism
20. 3H]-thymidine incorporation assay
21. Interleukin-6 prevents dexamethasone-induced myeloma cell death
22. A rapid single-laser flow cytometric method for discrimination of early apoptotic cells in a heterogenous cell population
23. A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cells
24. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma
25. Vinorelbine: An overview
26. Disposition of synthetic glucocorticoids. Part I. Pharmacokinetics of dexamethasone in healthy adults